IBDEI0QD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12964,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,12964,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,12964,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,12965,0)
 ;;=176.9^^78^810^20
 ;;^UTILITY(U,$J,358.3,12965,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12965,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,12965,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,12965,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,12966,0)
 ;;=161.9^^78^810^21
 ;;^UTILITY(U,$J,358.3,12966,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12966,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,12966,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,12966,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,12967,0)
 ;;=208.90^^78^810^22
 ;;^UTILITY(U,$J,358.3,12967,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12967,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,12967,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,12967,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,12968,0)
 ;;=140.9^^78^810^24
 ;;^UTILITY(U,$J,358.3,12968,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12968,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,12968,1,2,0)
 ;;=2^LIP CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,12968,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,12969,0)
 ;;=155.0^^78^810^25
 ;;^UTILITY(U,$J,358.3,12969,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12969,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,12969,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,12969,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,12970,0)
 ;;=200.60^^78^810^27
 ;;^UTILITY(U,$J,358.3,12970,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12970,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,12970,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,12970,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,12971,0)
 ;;=200.20^^78^810^28
 ;;^UTILITY(U,$J,358.3,12971,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12971,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,12971,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,12971,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,12972,0)
 ;;=201.90^^78^810^29
 ;;^UTILITY(U,$J,358.3,12972,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12972,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,12972,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,12972,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,12973,0)
 ;;=200.70^^78^810^30
 ;;^UTILITY(U,$J,358.3,12973,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12973,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,12973,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,12973,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,12974,0)
 ;;=200.40^^78^810^31
 ;;^UTILITY(U,$J,358.3,12974,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12974,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,12974,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,12974,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,12975,0)
 ;;=200.30^^78^810^32
 ;;^UTILITY(U,$J,358.3,12975,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12975,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,12975,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,12975,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,12976,0)
 ;;=200.50^^78^810^34
 ;;^UTILITY(U,$J,358.3,12976,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12976,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,12976,1,2,0)
 ;;=2^LYMPHOMA,PRIM CTR NERVOUS SYS
 ;;^UTILITY(U,$J,358.3,12976,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,12977,0)
 ;;=202.90^^78^810^33
 ;;^UTILITY(U,$J,358.3,12977,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12977,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,12977,1,2,0)
 ;;=2^LYMPHOMA,OTHER SITE
 ;;^UTILITY(U,$J,358.3,12977,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,12978,0)
 ;;=200.10^^78^810^35
